Publications by authors named "Gareth Gregory"

27Publications

Failure of tofacitinib to achieve an objective response in a T-lymphoblastic leukemia with activating mutations.

Cold Spring Harb Mol Case Stud 2020 Aug 25;6(4). Epub 2020 Aug 25.

Department of Hematology, Monash Health, Clayton, 3168, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/mcs.a004994DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476415PMC
August 2020

Disseminated Lomentospora prolificans infection in a patient on idelalisib-rituximab therapy for relapsed chronic lymphocytic leukaemia.

Ann Hematol 2020 Oct 25;99(10):2455-2456. Epub 2020 May 25.

School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-020-04087-2DOI Listing
October 2020

A consensus statement on the use of biosimilar medicines in hematology in Australia.

Asia Pac J Clin Oncol 2020 Aug 14;16(4):211-221. Epub 2020 Apr 14.

Monash Haematology, Monash Health, Clayton, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.13337DOI Listing
August 2020

Efficacy of Zanubrutinib in the Treatment of Bing-Neel Syndrome.

Hemasphere 2018 Dec 30;2(6):e155. Epub 2018 Nov 30.

Department of Hematology, Monash Health, Clayton, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HS9.0000000000000155DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745965PMC
December 2018

Cold agglutinin disease complicated by acrocyanosis and necrosis.

Ann Hematol 2017 Mar 3;96(3):509-510. Epub 2017 Jan 3.

Monash Haematology, Monash Health, Level 4, 246 Clayton Road, Clayton, 3168, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2905-6DOI Listing
March 2017

BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members.

Mol Cancer Ther 2016 09 12;15(9):2030-41. Epub 2016 Jul 12.

Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0924DOI Listing
September 2016

Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma.

Ann Hematol 2016 Mar 23;95(4):667-8. Epub 2016 Jan 23.

Monash Haematology, Monash Medical Centre, Level 4, 246 Clayton Road, Clayton, VIC, Australia, 3168.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2601-6DOI Listing
March 2016

Prevention and management of obinutuzumab-associated toxicities: Australian experience.

Int J Nurs Pract 2015 Dec;21 Suppl 3:15-27

Monash Haematology, Monash Health, Clayton, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijn.12412DOI Listing
December 2015

The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia.

Cancer Res 2016 Mar 1;76(5):1158-69. Epub 2015 Dec 1.

Gene Regulation Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-1070DOI Listing
March 2016

Rational combination therapies targeting survival signaling in aggressive B-cell leukemia/lymphoma.

Curr Opin Hematol 2014 Jul;21(4):297-308

aCancer Therapeutics Program, Gene Regulation Laboratory, The Peter MacCallum Cancer Centre, Melbourne bMonash Haematology, Monash Medical Centre cSouthern Clinical School, Monash University, Faculty of Medicine, Dentistry and Health Sciences, Clayton dSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00062752-201407000-000
Publisher Site
http://dx.doi.org/10.1097/MOH.0000000000000045DOI Listing
July 2014

Rituximab is associated with improved survival for aggressive B cell CNS lymphoma.

Neuro Oncol 2013 Aug 15;15(8):1068-73. Epub 2013 Mar 15.

Inter-hospital Multi-institution Project Alliance and Collaboration Taskforce, Monash Medical Centre, Clayton, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/not032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714147PMC
August 2013

Disseminated histoplasmosis complicating HIV infection.

Blood 2012 Dec;120(26):5101

Department of Clinical Hematology and Alfred Pathology Service, The Alfred Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-08-453423DOI Listing
December 2012

Passenger lymphocyte syndrome after lung transplant.

Blood 2012 Nov;120(20):4122

The Alfred Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-06-438614DOI Listing
November 2012

Failure of eculizumab to correct paroxysmal cold hemoglobinuria.

Ann Hematol 2011 Aug 26;90(8):989-90. Epub 2010 Nov 26.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-010-1123-xDOI Listing
August 2011